Cyprus health insurance organization updates medication formulary and inventory

The Health Insurance Organization (HIO) of Cyprus has announced the inclusion of three new pharmaceutical products in the General Healthcare System (Gesy) formulary, effective November 2, 2026. The newly added items include Trimbow pressurized inhalation solution (in two dosages: 87 mcg/5 mcg/9 mcg and 88 mcg/5 mcg/9 mcg) and the antibiotic Cefimed 400 mg film-coated tablets. These additions followed recommendations by the Pharmaceutical Advisory Committee and board approval to ensure improved access for beneficiaries.

In a separate development, the HIO announced on November 5, 2026, the procurement of additional supplies of digoxin and phenoxymethylpenicillin to address shortages, available through Marathon Distributors Ltd. Patients do not require new prescriptions for these items. Conversely, the organization noted that the current stock of deferiprone 500 mg has been exhausted, prompting concerns regarding inventory stability. The HIO mandates that doctors and pharmacies strictly follow Gesy prescription protocols for all managed medications to maintain continuous supply across the country for patients with serious health conditions.